[ad_1]
Shares of Mereo BioPharma Group plc – Sponsored ADR (NASDAQ:MREO – Get Free Report) have been assigned an average rating of “Buy” from the five analysts that are covering the firm, Marketbeat Ratings reports. Four analysts have rated the stock with a buy recommendation and one has assigned a stro
[ad_2]
Source link